Multimorbidity in Atherosclerotic Cardiovascular Disease and Its Associations With Adverse Cardiovascular Events and Healthcare Costs: A Real-World Evidence Study
**Background:** Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of mortality and disability in the United States and worldwide. **Objective:** To assess the multimorbidity burden and its associations with adverse cardiovascular events (ACE) and healthcare costs among patien...
Saved in:
Main Authors: | Dingwei Dai, Joaquim Fernandes, Xiaowu Sun, Laura Lupton, Vaughn W. Payne, Alexandra Berk |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2024-03-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.94710 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of adverse cardiovascular events following spinal cord injury in patients with osteoporosis: Real-world evidence
by: Shih-Kai Kao, et al.
Published: (2025-03-01) -
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis
by: Aldo Bonaventura, et al.
Published: (2016-01-01) -
A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients
by: Bo Dai, et al.
Published: (2025-01-01) -
Secondary Prevention Using Cholesterol-Lowering Medications in Patients with Prior Atherosclerotic Cardiovascular Disease Events: A Retrospective Cohort Analysis
by: Xue Han, et al.
Published: (2022-01-01) -
Association of glucose to lymphocyte ratio with the risk of death in patients with atherosclerotic cardiovascular disease
by: Jinglin Lei, et al.
Published: (2025-01-01)